Outlook Therapeutics
OTLK
OTLK
63 hedge funds and large institutions have $9.31M invested in Outlook Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 17 closing their positions.
Holders
63
Holders Change
–
Holders Change %
0%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
15
Reduced
18
Closed
17
Calls
$31K
Puts
$14K
Net Calls
+$17K
Net Calls Change
-$25K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2M |
| 2 |
2
Morgan Stanley
New York
|
$681K |
| 3 |
3
Millennium Management
New York
|
$542K |
| 4 |
4
Squarepoint
New York
|
$249K |
| 5 |
5
Renaissance Technologies
New York
|
$170K |
